Videos

Highlighting Geographic, Economic Disparities in Cancer Care

January 31st 2023, 10:00pm

Jumping Through Insurance Hoops for Treatment

January 31st 2023, 10:00pm

As a part of its “Speaking Out” video series, CURE® spoke with Dr. Miriam Atkins, on behalf of the Community Oncology Alliance, about the challenges patients and physicians face with insurance matters during cancer care.

Aimee's Dad

January 31st 2023, 8:22pm

Donna's Story

January 31st 2023, 8:21pm

SBRT Reduces Side Effects, Treatment Visits in Pancreatic Cancer

January 24th 2023, 10:00pm

Patients with pancreatic cancer who underwent stereotactic body radiation tended to have fewer side effects and treatment sessions compared to those who had intensity-modulated radiation therapy.

‘Profound’ Evidence Shows Breathing Can Improve Cancer-Related Pain and Stress

January 17th 2023, 8:00pm

While some may say that teaching breathing techniques gives patients with cancer the “heebie-jeebies”, it can actually have a major impact on patients’ pain and stress, according to an expert.

MF Progression to Acute Myeloid Leukemia and Subsequent Treatment

January 12th 2023, 2:00pm

Before closing out their program on myeloproliferative neoplasms, Rami Komrokji, MD, and Ruben Mesa, MD, discuss the potential for progression of MF to acute myeloid leukemia and highlight key treatment strategies.

Myelofibrosis: Novel Treatment Strategies and Combination Therapies

January 5th 2023, 2:05pm

Comprehensive discussion on the management of myelofibrosis, covering both monotherapy and combination therapy strategies.

Novel Treatment Strategies in Essential Thrombocythemia and Polycythemia Vera

January 5th 2023, 2:00pm

Focusing on clinical trials and novel therapies, Rami Komrokji, MD, and Ruben Mesa, MD, share their hope for the future management of essential thrombocythemia and polycythemia vera.

Adverse Events Tied to Treatment for Myeloproliferative Neoplasms

December 29th 2022, 2:05pm

Expert perspectives on the possible adverse events patients may encounter while receiving treatment for myeloproliferative neoplasms.